Terlivaz .85 mg/5mL
Terlipressin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Mallinckrodt Hospital Products Inc.
Terlivaz is a injection, powder, lyophilized, for solution containing terlipressin at .85 mg/5mL, taken intravenous. Manufactured by Mallinckrodt Hospital Products Inc..
Key Facts
- Brand Name
- Terlivaz
- Generic Name
- Terlipressin
- NDC Code (Product)
43825-200- Manufacturer
- Mallinckrodt Hospital Products Inc.
- Strength
- .85 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA022231
- Drug Class
- Vasopressin Receptor Agonist [EPC]
- Marketing Start
- 09/14/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Terlivaz used for?
Terlivaz contains Terlipressin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Terlivaz a controlled substance?
Terlivaz is not classified as a controlled substance by the DEA.
What is the generic name for Terlivaz?
The generic name for Terlivaz is Terlipressin. There are no other listed brand versions of Terlipressin.
What is the NDC code for Terlivaz .85 mg/5mL?
The NDC (National Drug Code) for Terlivaz .85 mg/5mL is 43825-200, listed by Mallinckrodt Hospital Products Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)